A Form 4 filed on August 25, 2026 reports that David Nicholas Gee, Chief Marketing Officer of Cellebrite DI Ltd. (NASDAQ:CLBT), sold 4,323 ordinary shares on August 24, 2026 pursuant to a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Shares sold: 4,323 ordinary shares (par value NIS 0.00001) disposed of on August 24, 2026.
  • Weighted average price: $11.3605 per share, with individual transactions ranging from $11.06 to $11.76, inclusive.
  • Post-transaction ownership: Gee directly holds 135,281 ordinary shares following the reported sale.
  • 10b5-1 plan: The sales were made under a Rule 10b5-1 trading plan adopted by Gee on November 18, 2025.
  • Reporting person role: David Nicholas Gee is identified as Chief Marketing Officer of Cellebrite DI Ltd.

Cellebrite CMO's Share Sale Details and Plan Context

According to the filing, David Nicholas Gee, Chief Marketing Officer of Cellebrite DI Ltd., disposed of 4,323 ordinary shares on August 24, 2026. The transaction is coded "S" (sale) and is classified as direct ownership. The filing indicates the sales were conducted in multiple transactions at prices ranging from $11.06 to $11.76 per share, with a weighted average price of $11.3605 reported in the filing. Gee's address is listed as 94 Shlomo Shmelzer Road, Petah Tikva, Israel.

The filing discloses that the sales were "effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025." The filing further notes that Gee "undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote." Following the reported transactions, Gee directly holds 135,281 ordinary shares of Cellebrite DI Ltd.

The Form 4 was filed on August 25, 2026, and covers a transaction with a date of earliest transaction of August 24, 2026. No derivative securities transactions were reported in Table II of the filing. The filing was made by one reporting person and bears the signature of David Nicholas Gee.

What Was Disclosed

Cellebrite DI Ltd.'s Chief Marketing Officer, David Nicholas Gee, reported the sale of 4,323 ordinary shares on August 24, 2026, at a weighted average price of $11.3605 per share under a pre-adopted Rule 10b5-1 plan, leaving him with direct ownership of 135,281 shares.